Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: AIDS Behav. 2013 Oct;17(8):2792–2801. doi: 10.1007/s10461-012-0386-8

Documentation of Psychiatric Disorders and Related Factors in a Large Sample Population of HIV-Positive Patients in California

Iman Parhami a,b,c,*, Timothy W Fong a,d, Aaron Siani d, Claudia Carlotti b, Homayoon Khanlou b
PMCID: PMC3628408  NIHMSID: NIHMS430098  PMID: 23247363

Abstract

This retrospective cohort study examined electronic medical records of HIV-positive patients in California (N=7,834) to find the prevalence of any psychiatric condition and the associations between several factors and the likelihood of these disorders. Approximately 53% of the patients in this study had a documented psychiatric condition, including 23% who had a mood disorder, 19% who had a substance-related disorder, and 16% who had an anxiety disorder. After controlling for potential confounders, significant positive associations (p<0.001) were found between female gender and the presence of any mood disorder (Adjusted Odds Ratio [95% Confidence Interval]=1.58[1.26–1.99]) or anxiety disorder (AOR=1.54[1.18–2.02]) and between homosexual orientation and the presence of any psychiatric condition (AOR=1.33[1.15–1.55]), mood disorder (AOR=1.71[1.42–2.07]), or anxiety disorder (AOR=1.41[1.22–1.88]). There were also significant negative associations between African American race and the presence of any psychiatric condition (AOR=0.68[0.60–0.77]), mood disorder (AOR=0.74[0.64–0.86]), anxiety disorder (AOR=0.43[0.36–0.52]), or substance-related disorder (AOR=0.78[0.67–0.91]) and between state/federal insurance and the presence of any psychiatric condition (AOR=0.70[0.62–0.79]), mood disorder (AOR=0.71[0.62–0.80]), or anxiety disorder (AOR=0.77[0.66–0.89]).

Keywords: AIDS, HIV, Psychiatric Disorders, Epidemiology

INTRODUCTION

A number of epidemiological studies have shown a substantial prevalence of psychiatric disorders in the HIV-positive population (1). Two studies that screened 2,864 and 1,125 HIV-positive patients found that 41 and 47 percent, respectively, of their samples met criteria for one or more psychiatric disorders (23). Because psychiatric comorbidity in HIV-positive patients is associated with decreased adherence to antiretroviral therapy (4), lower quality of life (5), higher health care costs (6), increased risk of suicide (7), more rapid progression of HIV infection (8), worse health outcomes, and ultimately increased mortality (9), the diagnosis of psychiatric disorder in HIV patients is of significant concern.

Mental health interventions for this population are effective in most instances, improving adherence to antiretrovirals (10), reducing risky sexual behaviors (11), and reducing the length of hospital stays (12). On a community level, mental health treatment decreases transmission rates by reducing community plasma viral loads and risky sexual behaviors (13). Fortunately, mental health care utilization is significantly greater among HIV-positive patients (14) than it is among the general public, where unmet need for mental health care is a serious public health problem (15). However, research suggests that utilization rates vary across populations based on several factors, such as race, employment status, insurance type, and socioeconomic class (14, 1620). In the clinical setting, a diagnosis is usually documented before patients are urged to seek treatment for their mental health disorders; this clinical diagnosis is also correlated with greater utilization of services and with improved well-being (21,22).

Factors related to the utilization of mental health services may also be related to the clinical diagnosis of mental health disorders, but there is very limited epidemiological research exploring this relationship in HIV clinics. To help bridge this gap, this study analyzed electronic medical records from multiple HIV health care clinics in California and explored the influences of demographic factors on diagnosis. It was hypothesized that the demographic factors that influence the utilization of mental health services may also affect the diagnosis of psychiatric conditions in the clinical setting. The primary objective of this study was to explore the effects of these factors on the diagnosis of any psychiatric condition. The secondary objective was to explore how these factors affect the diagnosis of the three mental ailments most common in this population: mood disorders, anxiety disorders, and substance-related disorders.

METHODS

This retrospective cohort study reviewed all electronic medical records of HIV-positive patients in California (N = 7,834) receiving treatment in ambulatory care clinics linked to AIDS Healthcare Foundation (AHF). AHF has thirteen healthcare centers in California and accepts any patient over the age of 18 regardless of ability to pay. Medical specialists, psychiatrists, psychologists, therapists, and social workers provide comprehensive care designed specifically for HIV-positive patients at these centers. The institutional review board at University of California, Los Angeles, granted approval for this study.

Data Abstraction

All medical records were downloaded in December 2011, and the data was compiled in a database. AHF uses diagnostic codes from the ninth edition of the International Classification of Diseases, Clinical Modification (ICD-9-CM) to classify all medical and psychiatric disorders, and AHF clinical providers (i.e., primary care physicians, psychiatrists, social workers, etc.) entered diagnostic codes and demographic data based on clinical judgment and on patients’ self-report. In the database, four dichotomized variables were listed for each patient indicating the presence or absence of any psychiatric condition (ICD-9 codes 290–319), any mood related disorder (ICD-9 codes 296.x), any anxiety related disorder (ICD-9 codes 300.x), and any substance related disorder (ICD-9 codes 291, 303–305). These three types of disorders were selected because they are the most prevalent in HIV-positive individuals (2,3).

Variables

To explore possible factors associated with the documentation of these psychiatric disorders, several covariates were analyzed: age, gender, sexual orientation, race, education, marital status, employment status, income, insurance type, HIV status, self-reported number of years since HIV diagnosis, and years since first visit to AHF. Age, self-reported number of years since first HIV diagnosis, and years since first visit to AHF were selected as potential continuum variables that may affect diagnosis of mental disorders: age (2326) and the number of years with HIV (17) affect disease progression as well as physical and mental health, and there may be an association between the presentation of mental disorders and the number of visits (27). The other covariates were based on AHF’s categorizations. Missing data was classified as “undocumented.”

Statistical Analysis

All patient data was included in the analysis. First, the distributions of patients with any psychiatric condition, any mood disorder, any anxiety disorder, and any substance-related disorder were calculated. Next, the relationships between the presence of these disorders and each covariate were assessed using two-sided chi-square tests or T-tests. Regression models were conducted to assess effect size. Multiple logistic regression models that controlled for confounding variables were also used to understand the relative effect sizes for each variable. Four separate models were created using the presence of any psychiatric condition and the presence of each type of psychiatric disorder (mood, anxiety, or substance-related) as the dependent variables and the potential confounding variables as the independent variables. Adjusted odds ratios (AOR) and 95 percent confident intervals (95CI) were reported. SPSS 19.0 was used for all analyses.

RESULTS

Cohort Description

Demographic characteristics are described in Table 1. On average, this cohort was 44 years old (SD=10.44), reported being diagnosed with HIV infection 8.67 years ago (SD=6.94), and first presented to AHF 4.50 years ago (SD=2.83). According to their ICD-9 diagnostic documentation, 53% (n=4,115) were diagnosed with any psychiatric condition, 23% (n=1,784) with a mood disorder, 16% (n=1264) with an anxiety disorder, and 19% (n=1,474) with a substance-related disorder. The majority of this sample was male (88%, n=6,932), homosexual (67%, n=5,238), single (64%, n=5,046), unemployed (56%, n=4,398), with income at or below poverty level (53%, n=4,135), and had federal/state insurance (70%, n=5,490) (Table 1).

Table 1.

Prevalence of any psychiatric condition and any mood, anxiety, and substance-related disorder

Characteristic Total Sample (N=7834) Any Psychiatric Condition (n=4115, 53%) Any Mood-Related Disorder (n=1784, 23%) Any Anxiety-Related Disorder (n=1264, 16%) Any Substance-Related Disorder (n= 1474, 19%)
Age (years)
Mean 43.57 44.28*** 45.19*** 44.53*** 42.05***
S.D. 10.44 9.88 9.24 9.79 9.50
Gender
Male 88% (6962) 52% (3634)*** 23% (1573) 16% (1124) 20% (1355)***
Female 9% (738) 50% (370) 25% (185) 16% (120) 12% (85)
Transgender 2% (128) 85% (109) 20% (25) 14% (18) 26% (33)
Undocumented 0.1% (6) 33% (2) 17% (1) 33% (2) 17% (1)
Sexual Orientation
Heterosexual 20% (1536) 48% (735)*** 19% (297)** 13% (202)*** 17% (259)***
Homosexual 67% (5238) 54% (2808) 24% (1243) 17% (913) 19% (987)
Bisexual 11% (869) 56% (487) 24% (207) 15% (128) 23% (200)
Undocumented 2% (191) 45% (85) 19% (37) 11% (21) 15% (28)
Race
White 37% (2888) 58% (1676)*** 26% (746)*** 21% (598)*** 21% (617)***
African-American 22% (1758) 51% (899) 22% (386) 11% (184) 20% (347)
Other 1% (93) 56% (52) 19% (18) 15% (14) 34% (32)
Undocumented 40% (3095) 48% (1488) 31% (634) 15% (468) 15% (478)
Education
Below HS Degree 9% (698) 50% (350)* 22% (150) 12% (84)* 16% (113)***
HS or vocational degree 39% (3075) 55% (1672) 24% (726) 16% (498) 22% (667)
Some college or higher 37% (2906) 53% (1525) 23% (676) 17% (495) 17% (497)
Undocumented 15% (1155) 49% (568) 20% (232) 16% (187) 17% (197)
Marital Status
Single 64% (5046) 54% (2727)*** 24% (1184)* 16% (820) 20% (1005)***
Married/Domestic Partner 6% (428) 46% (197) 18% (75) 14% (59) 13% (56)
Separated/Divorced/Widowed 1% (92) 48% (44) 23% (21) 15% (14) 14% (13)
Undocumented 29% (2268) 51% (1147) 22% (504) 16% (371) 18% (400)
Employment Status
Employed 40% (3092) 44% (1363)*** 17% (517)*** 14% (434)*** 13% (409)***
Unemployed 56% (4398) 59% (2576) 27% (1196) 17% (765) 23% (1015)
Undocumented 4% (344) 51% (176) 21% (71) 19% (65) 15% (50)
Income
Equal or below Poverty Level 53% (4135) 56% (2294)*** 25% (1025)*** 17% (694) 21% (868)***
101–200% of Poverty Level 24% (1912) 50% (956) 23% (431) 16% (303) 16% (306)
> 200% of Poverty Level 9% (683) 46% (316) 17% (119) 13% (90)
Undocumented 14% (1104) 50% (549) 19% (209) 16% (106) 19% (210)
Insurance Type
Private 26% (1973) 61% (1195)*** 30% (590)*** 20% (395)*** 19% (371)*
Federal/State 70% (5490) 50% (2727) 21% (1124) 15% (821) 18% (1012)
None/Self-Pay 1% (54) 41% (22) 13% (7) 6% (3) 19% (10)
Undocumented 4% (317) 54% (171) 20% (63) 14% (45) 26% (81)
HIV Status
Asymptomatic No AIDS 30% (2353) 47% (1101)*** 18% (415)*** 14% (324)** 19% (440)***
Symptomatic No AIDS 30% (2336) 57% (1339) 25% (586) 18%(410) 21% (489)
AIDS 38% (2971) 54% (1616) 26% (765) 17% (505) 18% (530)
Undocumented 2% (174) 34% (59) 10% (18) 14% (25) 9% (15)
Years since HIV Diagnosis
Mean 8.67 9.26*** 10.13*** 9.55*** 8.11***
S.D. 6.94 6.98 6.98 6.98 6.79
Years Since First AHF Visit
Mean 4.50 4.77*** 5.09*** 4.97*** 4.37*
S.D. 2.83 2.76 2.67 2.70 2.79

For all columns except first, reported percentage indicate the percent of patients with diagnoses per characteristic. First column indicates percent of sample per characteristic.

Chi-square or T-test analysis conducted to analyze differences per characteristic (*: 0.05≤p<0.01;**: 0.01≤p<0.001;***: p≤0.001)

Differences Based on Covariates

There was a statistical difference (p≤0.001) between the presence of any psychiatric condition and each of the factors (age, gender, sexual orientation, race, education, marital status, employment status, income, insurance type, HIV status, years since first HIV diagnosis, and years since first AHF visit) (see Table 1 and Table 2). There were also statistical differences between the presence of any mood disorder, anxiety disorder, or substance-related disorder and many of these factors (see Table 1 and Table 2).

Table 2.

Association Between Presence of Any Psychiatric Condition and Any Mood, Anxiety, and Substance-Related Disorder (Odds Ratio and 95 Percent CI)

Characteristic Any Psychiatric Condition Any Mood-Related Disorder Any Anxiety-Related Disorder Any Substance-Related Disorder
Age (years) 1.01 (1.01–1.02)*** 1.02 (1.01–1.03)*** 1.01 (1.01–1.02)*** 0.98 (0.98–0.99)***
Gender
Male 1 1 1 1
Female 0.92 (0.79–1.07) 1.15 (0.96–1.37) 1.01 (0.82–1.24) 0.54 (0.43–0.68)***
Transgender 5.25 (3.22–8.57)*** 0.83 (0.54–1.29) 0.85 (0.51–1.41) 1.44 (0.96–2.15)
Undocumented 0.46 (0.08–2.50) 0.69 (0.08–5.87 2.60 (0.48–14.20) 0.83 (0.10–7.09)
Sexual Orientation
Heterosexual 1 1 1 1
Homosexual 1.26 (1.12–1.41)*** 1.30 (1.13–1.50)*** 1.39 (1.18–1.64)*** 1.15 (0.99–1.33)
Bisexual 1.39 (1.18–1.64)*** 1.30 (1.07–1.60)* 1.14 (0.90–1.45) 1.47 (1.20–1.81)***
Undocumented 0.87 (0.65–1.18) 1.00 (0.69–1.47) 0.82 (0.51–1.31) 0.85 (0.56–1.29)
Race
White 1 1 1 1
African-American 0.76 (0.67–0.85)*** 0.81 (0.70–0.93)** 0.45 (0.38–0.53)*** 0.91 (0.78–1.05)
Other 0.92 (0.61–1.39) 0.69 (0.41–1.16) 0.68 (0.38–1.21) 1.93 (1.25–2.99)**
Undocumented 0.67 (0.61–0.74)*** 0.74 (0.66–0.84)*** 0.68 (0.60–0.78)*** 0.67 (0.59–0.77)***
Education
Below HS Degree 1 1 1 1
HS or vocational degree 1.19 (1.01–1.40)* 1.13 (0.93–1.38) 1.41 (1.10–1.81)** 1.43 (1.15–1.79)***
Some college or higher 1.10 (0.93–1.30) 1.11 (0.91–1.35) 1.50 (1.17–1.92)*** 1.07 (0.85–1.34)
Undocumented 0.96 (0.80–1.16) 0.92 (0.73–1.16) 1.41 (1.07–1.86)* 1.06 (0.83–1.37)
Marital Status
Single 1 1 1 1
Married/Domestic Partner 0.73 (0.60–0.88)*** 0.69 (0.54–0.90)** 0.82 (0.62–1.10) 0.61 (0.45–0.81)***
Separated/Divorced/Widowed 0.78 (0.52–1.18) 0.97 (0.59–1.58) 0.93 (0.52–1.64) 0.66 (0.37–1.19)
Undocumented 0.87 (0.79–0.96)** 0.93 (0.83–1.05) 1.01 (0.88–1.15) 0.86 (0.76–0.98)*
Employment Status
Employed 1 1 1 1
Unemployed 1.79 (1.63–1.97)*** 1.86 (1.66–2.09)*** 1.29 (1.14–1.47)*** 1.97 (1.74–2.23)***
Undocumented 1.33 (1.06–1.66)* 1.30 (0.98–1.71) 1.43 (1.07–1.90)* 1.12 (0.81–1.53)
Income
Equal or below Poverty Level 1 1 1 1
101–200% of Poverty Level 0.80 (0.72–0.90)*** 1.41 (1.20–1.67)*** 1.18 (0.98–1.42) 1.13 (0.96–1.34)
> 200% of Poverty Level 0.69 (0.59–0.81)*** 1.25 (1.04–1.50)* 1.10 (0.90–1.36) 0.81 (0.67–0.99)*
Undocumented 0.79 (0.70–0.91)*** 0.90 (0.71–1.16) 1.08 (0.83–1.40) 0.65 (0.49–0.85)***
Insurance Type
Private 1 1 1 1
Federal/State 0.64 (0.58–0.71)*** 0.60 (0.54–0.68)*** 0.70 (0.62–0.80)*** 0.98 (0.86–1.11)
None/Self-Pay 0.45 (0.26–0.78)** 0.35 (0.16–0.78)** 0.24 (0.07–0.76)* 0.98 (0.49–1.97)
Undocumented 0.76 (0.60–0.97)* 0.58 (0.43–0.78)*** 0.66 (0.47–0.92)* 1.48 (1.12–1.95)**
HIV Status
Asymptomatic No AIDS 1 1 1 1
Symptomatic No AIDS 1.53 (1.36–1.71)*** 1.56 (1.36–1.80)*** 1.33 (1.14–1.56)*** 1.15 (1.00–1.33)
AIDS 1.36 (1.22–1.51)*** 1.62 (1.42–1.85)*** 1.28 (1.10–1.49)*** 0.94 (0.82–1.10)
Undocumented 0.58 (0.42–0.81)*** 0.54 (0.33–0.89)* 1.05 (0.68–1.63) 0.41 (0.24–0.70)***
Years since HIV Diagnosis 1.03 (1.02–1.03)*** 1.04 (1.03–1.05)*** 1.02 (1.01–1.03)*** 0.99 (0.98–0.99)***
Years Since First AHF Visit 1.08 (1.06–1.09)*** 1.10 (1.08–1.12)*** 1.07 (1.05–1.10)*** 0.98 (0.96–1.00)
*

0.05≤p<0.01;

**

0.01≤p<0.001;

***

p≤0.001

Association with Covariates

Patients with any documented psychiatric condition were statistically (p≤0.001) more likely to be transgender (Odds Ratio [95 Confidence Interval]: 5.25[3.22–8.57]) compared to male; to be homosexual (1.26[1.12–1.41]) or bisexual (1.39[1.18–1.64]) compared to heterosexual; to be unemployed (1.79[1.63–1.97]) compared to employed; and to have symptomatic HIV (1.53[1.36–1.71]) or AIDS (1.36[1.22–1.51]) compared to asymptomatic HIV. In addition, patients with a documented psychiatric condition were statistically (p≤0.001) less likely to be African-American (0.76[0.67–0.85]) compared to White; to be married or with a domestic partner (0.76[0.60–0.88]) compared to single; to report income that was 101–200% of poverty level (0.80 [0.72–0.90]) or greater than 200% of poverty level (0.69 [0.59–0.81]) compared to at or below poverty level; and to have federal/state insurance (0.64 [0.58–0.71]) or self-pay/no insurance (0.45 [0.26–0.78]) compared to private insurance (Table 2). After controlling for potential confounders, statistical relationships still existed between the documentation of a psychiatric condition and several factors, including transgender, homosexual orientation, bisexual orientation, African-American race, unemployed status, income of 101–200% of poverty level, income greater than 200% of poverty level, federal/state insurance, and symptomatic HIV (see Table 3).

Table 3.

Association Between Presence of Any Psychiatric Condition and Any Mood, Anxiety, and Substance-Related Disorder After Controlling for Potential Confounders (Adjusted Odds Ratio and 95 Percent CI)

Characteristic Any psychiatric condition Any mood-related disorder Any anxiety-related disorder Any substance-related disorder
Age (years) 1.00 (1.00–1.01) 1.00 (1.00–1.01) 1 (0.99–1.01) 0.98 (0.97–0.99)***
Gender
Male 1 1 1 1
Female 1.07 (0.89–1.30) 1.58 (1.26–1.99)*** 1.54 (1.18–2.02)*** 0.48 (0.36–0.62)***
Transgender 5.14 (3.13–8.45)*** 0.74 (0.47–1.16) 0.87 (0.52–1.45) 1.37 (0.91–2.07)
Undocumented 0.51 (0.09–2.88) 1.05 (0.12–9.45) 4.31 (0.76–24.58) 0.48 (0.05–4.22)
Sexual Orientation
Heterosexual 1 1 1 1
Homosexual 1.33 (1.15–1.55)*** 1.71 (1.42–2.07)*** 1.51 (1.22–1.88)*** 0.84 (0.70–1.02)
Bisexual 1.39 (1.15–1.69)*** 1.54 (1.22–1.95)*** 1.24 (0.94–1.64) 1.05 (0.83–1.32)
Undocumented 0.98 (0.71–1.35) 1.29 (0.86–1.92) 0.80 (0.48–1.31) 0.75 (0.48–1.18)
Race
White 1 1 1
African-American 0.68 (0.60–0.77)*** 0.74 (0.64–0.86)*** 0.43 (0.36–0.52)*** 0.78 (0.67–0.91)**
Other 0.93 (0.60–1.44) 0.71 (0.42–1.21) 0.69 (0.38–1.24) 1.82 (1.16–2.87)**
Undocumented 0.67 (0.60–0.75)*** 0.79 (0.69–0.90)*** 0.73 (0.64–0.84)*** 0.61 (0.53–0.70)***
Education
Below HS Degree 1 1 1
HS or vocational degree 1.17 (0.98–1.40) 1.15 (0.93–1.41) 1.46 (1.13–1.89)** 1.23 (0.98–1.55)
Some college or higher 1.11 (0.93–1.34) 1.17 (0.94–1.46) 1.53 (1.18–2.00)** 0.92 (0.72–1.17)
Undocumented 1.05 (0.86–1.29) 1.08 (0.84–1.38) 1.59 (1.19–2.13)** 0.96 (0.74–1.26)
Marital Status
Single 1 1 1
Married/Domestic Partner 0.77 (0.63–0.95)* 0.72 (0.55–0.94)* 0.88 (0.65–1.18) 0.69 (0.51–0.94)*
Separated/Divorced/Widowed 0.80 (0.52–1.22) 0.99 (0.59–1.64) 1.02 (0.57–1.84) 0.76 (0.42–1.41)
Undocumented 0.84 (0.76–0.93)*** 0.90 (0.80–1.02) 0.96 (0.84–1.11) 0.88 (0.77–1.00)
Employment Status
Employed 1 1 1
Unemployed 1.72 (1.56–1.91)*** 1.76 (1.56–2.00)*** 1.36 (1.19–1.56)*** 1.93 (1.68–2.20)***
Undocumented 1.32 (1.04–1.66)* 1.22 (0.92–1.64) 1.42 (1.05–1.92)* 1.21 (0.87–1.68)
Income
Equal or below Poverty Level 1 1 1
101–200% of Poverty Level 0.77 (0.68–0.86)*** 0.81 (0.71–0.93)** 0.87 (0.74–1.01) 0.81 (0.69–0.94)**
> 200% of Poverty Level 0.72 (0.60–0.86)*** 0.66 (0.53–0.83)*** 0.81 (0.64–1.03) 0.71 (0.56–0.91)**
Undocumented 0.86 (0.75–0.99)* 0.75 (0.63–0.90)*** 0.86 (0.71–1.05) 0.95 (0.79–1.13)
Insurance Type
Private 1 1 1
Federal/State 0.70 (0.62–0.79)*** 0.71 (0.62–0.80)*** 0.77 (0.66–0.89)*** 0.90 (0.78–1.04)
None/Self-Pay 0.58 (0.33–1.01) 0.50 (0.22–1.13) 0.30 (0.09–0.97)* 0.95 (0.47–1.96)
Undocumented 0.84 (0.65–1.08) 0.71 (0.53–0.97)* 0.74 (0.52–1.04) 1.25 (0.94–1.68)
HIV Status
Asymptomatic No AIDS 1 1 1
Symptomatic No AIDS 1.34 (1.19–1.51)*** 1.33 (1.15–1.54)*** 1.22 (1.04–1.44)* 1.15 (0.99–1.34)
AIDS 1.03 (0.91–1.16) 1.15 (0.99–1.33) 1.05 (0.89–1.24) 0.96 (0.82–1.12)
Undocumented 0.69 (0.49–0.96)* 0.67 (0.40–1.13) 1.32 (0.84–2.09) 0.34 (0.19–0.60)***
Years since HIV Diagnosis 1.01 (1.00–1.02) 1.02 (1.01–1.03)** 1.00 (0.99–1.02) 0.99 (0.98–1.00)
Years Since First AHF Visit 1.06 (1.04–1.08)*** 1.06 (1.03–1.09)*** 1.07 (1.03–1.10)*** 1.03 (1.00–1.06)
*

0.05≤p<0.01;

**

0.01≤p<0.001;

***

p≤0.001

Any Mood, Anxiety, or Substance-related Disorders

The relationships between the covariates and the documentation of specific disorder types did not always match the relationships found between the covariates and the documentation of any psychiatric condition. When the three types of psychiatric disorders were analyzed separately, females, compared to males, were statistically more likely (p≤0.001) to have any mood disorder (1.58 [1.26–1.99]) or anxiety disorder (1.54 [1.18–2.02]) and less likely to have any substance-related disorder (0.48 [0.36–0.62]). Homosexuals, compared to heterosexuals, were not more likely to have any substance-related disorder (0.84 [0.70–1.02], p>0.05) but were more likely (p≤0.001) to have any mood disorder (1.71 [1.42–2.07]) or anxiety disorder (1.51 [1.22–1.88]); bisexuals, compared to heterosexuals, were more likely to have any mood disorder (1.54 [1.22–1.95]) (see Table 3).

After controlling for potential confounders, notable negative relationships (p≤0.001 unless noted) between the covariates and the presence of specific disorder types that were similar to the relationship between the covariates and the presence of any psychiatric condition included African Americans and mood disorders (0.74 [0.64–0.86]), anxiety disorders (0.43 [0.36–0.52]), and substance-related disorders (0.78 [0.67–0.91], p=0.002) and federal/state insurance and mood disorders (0.71 [0.62–0.80]) and anxiety disorders (0.77 [0.66–0.89]). Similar positive relationships included unemployed status and any mood disorder (1.76 [1.56–2.00]), anxiety disorder (1.36 [1.19–1.56]), or substance-related disorder (1.93 [1.68–2.20]). The relationships between years since first AHF visit and any mood disorder (1.06[1.03–1.09]) and between years since first AHF visit and any anxiety disorder (1.07[1.03–1.10]) were also similar to the relationship between this covariate and any psychiatric condition (see Table 3).

DISCUSSION

This study explored the documentation of psychiatric disorders, including mood, anxiety, and substance-related disorders, in a large clinical sample of HIV-positive patients (N=7,834). The prevalence rate of psychiatric conditions in this sample (53%) confirms the findings of previous epidemiological studies that demonstrate a high proportion of HIV-positive patients with psychiatric comorbidity, especially comorbid mood (23%), anxiety (16%), and substance-related disorders (19%)(see Table 1) (2,3). This study found rates similar to those found in previous studies, and this study noted several covariates that were strongly related to the documentation of psychiatric conditions.

Gender and Sexual Orientation

The prevalence of specific types of psychiatric disorders were found to differ based on gender and sexual orientation. Although approximately half of the males and females in this sample had a documented psychiatric condition, after controlling for confounding variables this study found that females were more likely to have mood or anxiety disorders and less likely to have substance-related disorders. This is similar to the distributions found in the general public (28) and in HIV clinics, which demonstrate a higher prevalence of psychiatric comorbidity in females (1, 2932). Compared to heterosexuals, homosexuals were more likely to have any psychiatric condition, mood disorder, or anxiety disorder, while bisexuals were more likely to have any psychiatric condition and any mood disorder, reinforcing the idea that non-heterosexuals may have increased problems with mental health (33,34).

Race

A lower prevalence of psychiatric conditions, including any mood, anxiety, or substance-related disorder, was found among African-Americans. This is congruent with results obtained by Pence and colleagues, who found that Caucasian HIV-infected patients were more likely to screen positive for mood and anxiety disorders than were members of any other race (3). Similarly, using a diagnostic screening, the HIV Cost and Services Utilization Study (HCSUS) reported lower rates of psychiatric diagnoses in HIV-positive African-Americans compared to Caucasians (2). Some speculation has arisen that lower detection rates of psychiatric disorders in minority populations may be due to disparities in health care (35). While some believe that minorities are at decreased risk for psychiatric disorders (36), others maintain that cultural factors affect both patient reporting and clinician interpretation of psychiatric disorders (37).

Insurance Type

This study found that patients with federally or state-funded insurance were less likely to have a documented psychiatric condition than those with private health insurance, reaffirming research that indicates insurance status may influence utilization of mental health services as well as outcomes (14, 3842). In the HCSUS study, those with state or private insurance, compared to those without insurance, were more likely to utilize mental health services, including medications, outpatient visits, and residential treatments (20). These findings suggest that while some populations may be at equally high risk for psychiatric conditions, their mental health issues may be less clinically recognized due to insurance type or lack of insurance.

Other Covariates

Two other findings were similar to the HCSUS study. First, unemployment was associated with an increased prevalence of psychiatric disorders (2), implying that employment is associated with better mental health for individuals living with HIV (43). Second, a higher number of years since the patient’s first visit to the clinic was associated with increased documentation of a psychiatric condition. This is similar to the HCSUS finding that under-diagnosis in patients’ charts correlated to the number of visits (44). This may imply either that psychiatric conditions become more pronounced as HIV progresses or that the mental health services available to HIV patients are inadequate for correctly diagnosing psychiatric conditions quickly (20).

Limitations and Future Research

The largest limitations of this study were the ambiguity in the source of documentation and the reliance on ICD-9-CM codes. Diagnostic codes listed in the electronic medical records were inserted by many different healthcare employees (physicians, nurses, social workers, psychologists, etc.), and it is unknown whether documentation was based on patient histories, diagnostic screens, or clinical judgment. The rates of diagnosis reported here, therefore, cannot be seen as approximations of clinical diagnostic rates because there is no evidence that diagnoses were reached through a standardized approach. Nevertheless, other researchers have utilized similar databases (i.e., Veterans’ Affairs national databases) and have used ICD-9-CM codes extensively for clinical epidemiological research (45). The second limitation of this study involves the complexities associated with recording patient characteristics. This information was not verified, recorded by different staff members, and missing for some. For one characteristic, 40% of the sample did not have a documented race. Since these clinics are located in communities with large Hispanic populations, missing racial data may be due to vague documentation of race for those with Hispanic descent. This impreciseness further exhibits the known challenges associated with racial and ethnicity clinical data (46). Another limitation was that the sample included only those patients presenting to AHF. While this may introduce sampling bias, the large sample size and the multiple AHF clinics included in this study provide some generalizability of these results to ‘real-world’ clinics treating HIV-positive individuals (47).

Clinically, this study highlights the need for effective recognition of psychiatric comorbidity in HIV-positive patients. Since research has demonstrated that psychiatric disorders and interventions have a substantial influence on physical as well as mental health outcomes for HIV-positive patients, certain populations may benefit from routine mental health screenings. Findings from this study can help HIV healthcare clinics create more focused and effective programs aimed at detecting patients with undiagnosed psychiatric disorders. Further research could also evaluate whether additional screening for patients with under-detected mental illnesses is clinically beneficial in utilization of mental health treatment services.

Acknowledgments

The authors would like to thank Dr. Karl Goodkin for reviewing and providing comments on an earlier version of this manuscript. The views expressed herein are not necessarily those of AIDS Healthcare Foundation.

Footnotes

None of the authors report any conflict of interest related to this work.

References

  • 1.Gallego L, Barreiro P, Lopéz-Ibor JJ. Diagnosis and Clinical Features of Major Neuropsychiatric Disorders in HIV Infection. AIDS Rev. 2011;13:171–179. [PubMed] [Google Scholar]
  • 2.Bing E, Burnam M, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–728. doi: 10.1001/archpsyc.58.8.721. [DOI] [PubMed] [Google Scholar]
  • 3.Pence B, Miller W, Whetten K, Eron J, Gaynes B. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr. 2006;42(3):298–306. doi: 10.1097/01.qai.0000219773.82055.aa. [DOI] [PubMed] [Google Scholar]
  • 4.Palmer N, Basinski J, Uldall K. Psychiatric illness, access and adherence to HAART: A brief review of recent findings and implications for care. HIV Ther. 2010;4(2):215–230. [Google Scholar]
  • 5.Sherbourne C, Hays R, Fleishman J, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157(2):248–254. doi: 10.1176/appi.ajp.157.2.248. [DOI] [PubMed] [Google Scholar]
  • 6.Rothbard A, Miller K, Lee S, Blank M. Revised Cost Estimates of Medicaid Recipients With Serious Mental Illness and HIV-AIDS. Psychiatr Serv. 2009;60(7):974–977. doi: 10.1176/ps.2009.60.7.974. [DOI] [PubMed] [Google Scholar]
  • 7.Keiser O, Spoerri A, Brinkhof M, et al. Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988–2008. Am J Psychiatry. 2010;167(2):143–150. doi: 10.1176/appi.ajp.2009.09050651. [DOI] [PubMed] [Google Scholar]
  • 8.Bangsberg D, Perry S, Charlebois E, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–1183. doi: 10.1097/00002030-200106150-00015. [DOI] [PubMed] [Google Scholar]
  • 9.Ickovics J, Hamburger M, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11):1466–1474. doi: 10.1001/jama.285.11.1466. [DOI] [PubMed] [Google Scholar]
  • 10.Johnson M, Charlebois E, Morin S, Remien R, Chesney M. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: The healthy living project randomized controlled study. J Acquir Immune Defic Syndr. 2007;46(5):574–580. doi: 10.1097/qai.0b013e318158a474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Morin S. Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: The healthy lving project randomized controlled study. J Acquir Immune Defic Syndr. 2007;44:213–21. doi: 10.1097/QAI.0b013e31802c0cae. [DOI] [PubMed] [Google Scholar]
  • 12.Whetten K, Reif S, Ostermann J, et al. Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast. AIDS Care. 2006;18:18–26. doi: 10.1080/09540120600839330. [DOI] [PubMed] [Google Scholar]
  • 13.Sikkema K, Watt M, Drabkin A, Meade C, Hansen N, Pence B. Mental health treatment to reduce HIV transmission risk behavior: A positive prevention model. AIDS and Behav. 2010;14(2):252–262. doi: 10.1007/s10461-009-9650-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58(8):729–736. doi: 10.1001/archpsyc.58.8.729. [DOI] [PubMed] [Google Scholar]
  • 15.Mojtabai R, Olfson M, Mechanic D. Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry. 2002;59(1):77–84. doi: 10.1001/archpsyc.59.1.77. [DOI] [PubMed] [Google Scholar]
  • 16.Cunningham WE, Sohler NL, Tobias C, et al. Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the US population in care. Med Care. 2006;44(11):1038–1047. doi: 10.1097/01.mlr.0000242942.17968.69. [DOI] [PubMed] [Google Scholar]
  • 17.Mkanta WN, Mejia MC, Duncan RP. Race, outpatient mental health service use, and survival after an AIDS diagnosis in the highly active antiretroviral therapy era. AIDS Patient Care STDs. 2010;24(1):31–37. doi: 10.1089/apc.2009.0177. [DOI] [PubMed] [Google Scholar]
  • 18.Himelhoch S, Josephs JS, Chander G, Korthuis PT, Gebo KA. Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study. Gen Hos Psychiatry. 2009;31(6):538–545. doi: 10.1016/j.genhosppsych.2009.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Reif S, Whetten K, Ostermann J, Raper JL. Characteristics of HIV-infected adults in the Deep South and their utilization of mental health services: a rural vs. urban comparison. AIDS Care. 2006;18(S1):10–17. doi: 10.1080/09540120600838738. [DOI] [PubMed] [Google Scholar]
  • 20.Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr. 2008;47(4):449–458. doi: 10.1097/QAI.0b013e3181642244. [DOI] [PubMed] [Google Scholar]
  • 21.Chatterjee S, Rath ME, Spiro A, III, Eisen S, Sloan KL, Rosen AK. Gender differences in veterans health administration mental health service use: effects of age and psychiatric diagnosis. Women’s Health Issues. 2009;19(3):176–184. doi: 10.1016/j.whi.2009.03.002. [DOI] [PubMed] [Google Scholar]
  • 22.DeLorenze GN, Satre DD, Quesenberry CP, Jr, Tsai AL, Weisner CM. Mortality After Diagnosis of Psychiatric Disorders and Co-Occurring Substance Use Disorders Among HIV-Infected Patients. AIDS Patient Care STDs. 2010;24(11):705–712. doi: 10.1089/apc.2010.0139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Goulet JL, Fultz SL, Rimland D, et al. Do Patterns of Comorbidity Vary by HIV Status, Age, and HIV Severity? Clin Infect Dis. 2007;45(12):1593–1601. doi: 10.1086/523577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Vance DE, Mugavero M, Willig J, Raper JL, Saag MS. Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care. 2011;22(1):17–25. doi: 10.1016/j.jana.2010.04.002. [DOI] [PubMed] [Google Scholar]
  • 25.Oursler KK, Goulet JL, Crystal S, et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the veterans aging cohort study. AIDS Patient Care STDs. 2011;25(1):13–20. doi: 10.1089/apc.2010.0242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–545. doi: 10.1097/PSY.0b013e3181777a5f. [DOI] [PubMed] [Google Scholar]
  • 27.Rhodes A, Liisa Jaakkimainen R, Bondy S, Fung K. Depression and mental health visits to physicians--a prospective records-based study. Soc Sci Med. 2006;62(4):828–834. doi: 10.1016/j.socscimed.2005.06.039. [DOI] [PubMed] [Google Scholar]
  • 28.Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602. doi: 10.1001/archpsyc.62.6.593. [DOI] [PubMed] [Google Scholar]
  • 29.Turner BJ, Laine C, Cosler L, Hauck WW. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV- infected drug users. J Gen Intern Med. 2003;18(4):248–257. doi: 10.1046/j.1525-1497.2003.20122.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cook JA, Cohen MH, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30(4):401–409. doi: 10.1097/00042560-200208010-00005. [DOI] [PubMed] [Google Scholar]
  • 31.Morrison MF, Petitto JM, Ten Have T, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002;159(5):789–796. doi: 10.1176/appi.ajp.159.5.789. [DOI] [PubMed] [Google Scholar]
  • 32.Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–789. doi: 10.2165/00003495-200666060-00004. [DOI] [PubMed] [Google Scholar]
  • 33.Dodge B, Sandfort TGM, Firestein B. A review of mental health research on bisexual individuals when compared to homosexual and heterosexual individuals. In: Firestein B, editor. Becoming visible: Counseling bisexuals across the lifespan. New York: Colombia University Press; 2007. pp. 28–51. [Google Scholar]
  • 34.Meyer I. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychol Bull. 2003;129(5):674–697. doi: 10.1037/0033-2909.129.5.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Stockdale S, Lagomasino I, Siddique J, McGuire T, Miranda J. Racial and ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995–2005. Med Care. 2008;46(7):668–677. doi: 10.1097/MLR.0b013e3181789496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Breslau J, Kendler K, Su M, Gaxiola-Aguilar S, Kessler R. Lifetime risk and persistence of psychiatric disorders across ethnic groups in the United States. Psychol Med. 2004;35(3):317–327. doi: 10.1017/s0033291704003514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.McGuire T, Miranda J. New evidence regarding racial and ethnic disparities in mental health: Policy implications. Health Aff. 2008;27(2):393–403. doi: 10.1377/hlthaff.27.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bhattacharya J, Goldman D, Sood N. The link between public and private insurance and HIV-related mortality. J Health Econ. 2003;22(6):1105–1122. doi: 10.1016/j.jhealeco.2003.07.001. [DOI] [PubMed] [Google Scholar]
  • 39.Goldstein RB, Rotheram-Borus MJ, Johnson MO, et al. Insurance coverage, usual source of care, and receipt of clinically indicated care for comorbid conditions among adults living with human immunodeficiency virus. Med Care. 2005;43(4):401–410. doi: 10.1097/01.mlr.0000156850.86917.f8. [DOI] [PubMed] [Google Scholar]
  • 40.Sturm R, Sherbourne CD. Are barriers to mental health and substance abuse care still rising? J Behav Health Serv Res. 2001;28(1):81–88. doi: 10.1007/BF02287236. [DOI] [PubMed] [Google Scholar]
  • 41.Wells KB, Sherbourne CD, Sturm R, Young AS, Audrey Burnam M. Alcohol, drug abuse, and mental health care for uninsured and insured adults. Health Serv Res. 2002;37(4):1055–1066. doi: 10.1034/j.1600-0560.2002.65.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Smith SR, Kirking DM. The effect of insurance coverage changes on drug utilization in HIV disease. J Acquir Immune Defic Syndr. 2001;28(2):140. doi: 10.1097/00126334-200110010-00005. [DOI] [PubMed] [Google Scholar]
  • 43.Rueda S, Raboud J, Mustard C, Bayoumi A, Lavis JN, Rourke SB. Employment status is associated with both physical and mental health quality of life in people living with HIV. AIDS Care. 2011;23(4):435–443. doi: 10.1080/09540121.2010.507952. [DOI] [PubMed] [Google Scholar]
  • 44.Asch S, Kilbourne A, Gifford A, et al. Underdiagnosis of depression in HIV. J Gen Intern Med. 2003;18(6):450–460. doi: 10.1046/j.1525-1497.2003.20938.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Nurutdinova D, Chrusciel T, Zeringue A, et al. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS. 2012;26(2):229–234. doi: 10.1097/QAD.0b013e32834e1404. [DOI] [PubMed] [Google Scholar]
  • 46.Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. JAMA. 2003;289:2709–16. doi: 10.1001/jama.289.20.2709. [DOI] [PubMed] [Google Scholar]
  • 47.Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47:S15–9. doi: 10.1097/QAI.0b013e3181605b26. [DOI] [PubMed] [Google Scholar]

RESOURCES